• We see a strong chance of FY19 results beating low expectations, but market estimates for FY20 look too heroic, leaving scope for some disappointment versus very stretched valuations. Be vigilant with high growth stocks in this context.
  • We think upside surprise to capital management may again feature in August. Investors have sought returns in defensively oriented names since the February reporting season.

Watch

FY20 forecasts vs stretched valuations leave little room for error

Stocks enter the August reporting season with very low expectations for FY19 on aggregate. Consensus expectations for FY19 EPS growth (excluding Resources stocks) have eroded from around 4.7% post February results to only 1% heading into August. This has been a persistent theme for 3-4 years now.

So while we think that results can clear this low hurdle for FY19, we do worry about:

  1. current consensus FY20 EPS growth expectations looking look too heroic at ~8%; and
  2. aggregate industrials valuations at a decade high 17.5x (12-month forward PE multiple) leaving very little room for error in FY20 outlook commentary versus consensus expectations.

Capital management once again in focus

Lower rates have again fueled the 'yield' trade. A mix of slowing economic growth, interest rate cuts and companies dialling back expansion capex have created an ideal environment for yield investors.

We think upside surprise to capital management may again feature in August. Investors have sought returns in defensively oriented names since the February reporting season.

However, we're uneasy about this dynamic in the context that EPS expectations, which support DPS expectations, have continued to erode.

Pay close attention to the sustainability of future capital returns.

Growth names have defined 2019

Our basket of Growth bellwethers has outpaced Value by 41% YTD (page 10), and this highlights the ongoing trend of high PE stocks re-rating further against the pool of lower valued stocks. The spread is now 18 PE points vs the 10-year average of 10.

A slowdown in the economic climate and falling interest rates have contributed to the appeal of growth, extending valuations further.

However, as the focus turns to domestic earnings and given expectations are higher than ever, we could be nearing the eventual cyclical turning point.


Morgans clients receive access to detailed market analysis and insights, provided by our award-winning research team. Begin your journey with Morgans today to view the exclusive coverage.

      
Contact us
      

Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.

News & Insights

This edition of the Month Ahead presents ideas from three areas of focus for Morgans: domestic equities, ETFs and global equities. We take a look at the opportunities presented by Light & Wonder, the Firetrail Australian Small Companies Fund and Eli Lilly.
Read full article
We recommend investors start making sense of AI by considering stock opportunities in three distinct areas: artificial intelligence, digital infrastructure, and data networks.
Read full article
Most results were thereabouts against expectations which saw the sector perform broadly in line with the index. Top picks are ALQ and CVL.
Read full article

News & Insights

We see a strong chance of FY19 results beating low expectations, but market estimates for FY20 look too heroic, leaving scope for some disappointment versus very stretched valuations.
Find out more